for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

EXCLUSIVE-India's Shilpa Medicare can make 100-200 mln doses of COVID-19 shot, says exec

BENGALURU, April 7 (Reuters) - Indian drugmaker Shilpa Medicare Ltd has the production capacity to make 100-200 million doses of a recombinant vaccine for COVID-19, a company executive told Reuters on Wednesday.

The company’s shares jumped as much as 9.2% on India’s National Stock Exchange following the news. (Reporting by Sachin Ravikumar in Bengaluru; Editing by Shounak Dasgupta)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up